CINVANTI

Discussion in 'Heron Therapeutics' started by anonymous, Nov 11, 2017 at 9:23 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What's the word on the new drug - excitement or another dog?
     

  2. anonymous

    anonymous Guest

    Complete Dog. They think we can bundle but most of my customers say they won’t use. Another Rosen swing and miss. Strike two.
     
  3. anonymous

    anonymous Guest

    Shit product. Having nothing but negative feedback from accounts.
     
  4. anonymous

    anonymous Guest

    So between Friday and Tuesday, you have met with “most” of your customers? I call BS. What is apparent from your message is that you want a drug that sells itself and doesn’t require you to use any selling skills. You get paid a salary, have a bonus plan with a target that is one of the best I have seen in pharma, and all you can do is whine. Time for you to leave.
     
  5. anonymous

    anonymous Guest

    And what is that feedback? Tell us, or are you simply FOS?
     
  6. anonymous

    anonymous Guest

    Go to your own board with the negativity!
     
  7. anonymous

    anonymous Guest

    OK, so maybe YOU tell us what the positives are. This is how I see it:

    Nobody sees a problem with emend (advantage emend unless cinvanti or varubi iv kills on price and provide a compelling reason to switch)

    Varubi IV is available now and cheaper than emend (advantage Varubi IV, disadvantage emend, cinvanti not yet available and price?)

    Cinvanti need IV bags which are not available (advantage Varubi IV with glass bottle, disadvantage cinvanti and emend)

    Looking pretty good for varubi IV right?
     
  8. anonymous

    anonymous Guest

    You don’t think indication / clinical data can be a competitive advantage vs Varubi?!? Delayed vs acute and delayed? If you are giving up already, then you don’t represent the best of Heron, just the worst. Please do a favor to my ABM colleagues and resign.
     
  9. anonymous

    anonymous Guest

    Can't wait for the launch meeting next week and listen to the BS on how we can sell this dog....
     
  10. anonymous

    anonymous Guest

    Why don't you do your ABM colleagues and me a favor and leave the company?!? Your attitude is a disease in itself...the bad apple that can rot the bushel. So get out! I hope that your RBD is able to figure out who you are and dumps your sorry a$$.

    I will tell you that I am an ABM and I will be listening for you...the person with negativity dripping off of them. I happen to enjoy the challenges we face and want to succeed - I don't want a negative person impacting my other ABM colleagues.
     
  11. anonymous

    anonymous Guest

    This is a hilarious post Rob. I’ll tell you to your face what people think about you and your sorry second rate VPs.
     
  12. anonymous

    anonymous Guest

    This week is going to a joke
     
  13. anonymous

    anonymous Guest

    Well... IV VARUBI seems to have blown itself up. It's just CINAVNTI and EMEND left on the shelf. What's the word?
     
  14. anonymous

    anonymous Guest

    You just said the word
     
  15. anonymous

    anonymous Guest

    Another crap drug with a poor results.